Hospital
Kay County Oklahoma Hospital Company LLC
Kay County Oklahoma Hospital Company LLC was paid $6.78M by Medicaid between Jan 2018 and Jan 2024, across 80 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.
33Billing provider infoKAY COUNTY OKLAHOMA HOSPITAL COMPANY LLC
PONCA CITY, OK 74601
PONCA CITY, OK 74601
33aNPI1225077035assigned 06/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.78M
24GClaims100,916
24DCodes billed80
24AFirst – last monthJan 2018 – Jan 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#22 of 75
Median peer was paid$3.66M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,998 | $919K | |
| 2019 | 11,757 | $803K | |
| 2020 | 7,607 | $590K | |
| 2021 | 16,422 | $1.09M | |
| 2022 | 24,124 | $1.59M | |
| 2023 | 26,001 | $1.70M | |
| 2024incomplete | 1,007 | $84K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 10,826 | 10,646 | $2.49M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 14,170 | 14,002 | $2.22M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7.0% | 3,755 | 3,699 | $476K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.1% | 1,044 | 1,032 | $275K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 2,317 | 2,302 | $216K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.7% | 2,529 | 2,453 | $115K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 1,574 | 1,545 | $100K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 577 | 570 | $95K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 1,800 | 1,783 | $86K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 5,474 | 2,745 | $77K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 11,002 | 10,451 | $74K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,241 | 1,228 | $67K |
68 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 426 | $55K |
| 80053 | Comprehensive metabolic panel | <1% | 6,332 | $54K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 540 | $45K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 934 | $43K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,399 | $30K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,454 | $27K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 370 | $16K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 695 | $15K |
| 80306 | <1% | 981 | $14K | |
| 80074 | <1% | 336 | $14K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 912 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 669 | $11K |
| 84703 | <1% | 1,520 | $10K | |
| 76801 | <1% | 161 | $9K | |
| 86762 | <1% | 677 | $9K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 13 | $9K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 138 | $8K |
| 81001 | <1% | 2,727 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,194 | $7K |
| 84439 | <1% | 839 | $7K | |
| 86850 | <1% | 818 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 822 | $6K |
| 83690 | <1% | 971 | $5K | |
| 86780 | <1% | 418 | $5K | |
| 84484 | <1% | 402 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 110 | $5K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 12 | $4K |
| 87807 | <1% | 334 | $4K | |
| 83735 | <1% | 634 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 67 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 212 | $3K |
| 87340 | <1% | 333 | $3K | |
| 81003 | <1% | 1,553 | $3K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 116 | $2K |
| 86900 | <1% | 848 | $2K | |
| 86901 | <1% | 837 | $2K | |
| 83605 | <1% | 176 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 217 | $2K |
| 82950 | <1% | 386 | $2K | |
| 87077 | <1% | 210 | $2K | |
| 82947 | <1% | 365 | $1K | |
| 87081 | <1% | 177 | $1K | |
| 86592 | <1% | 269 | $1K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 12 | $855.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 13 | $620.01 |
| 82550 | <1% | 116 | $596.56 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,217 | $509.10 |
| 82247 | <1% | 86 | $406.75 | |
| 82248 | <1% | 84 | $397.31 | |
| 83880 | <1% | 12 | $384.12 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | $372.79 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 41 | $350.29 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 223 | $223.55 |
| 85610 | <1% | 39 | $139.16 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,067 | $76.67 |
| 86140 | <1% | 12 | $55.32 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 104 | $7.43 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 645 | $3.38 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 52 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 723 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 28 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 43 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 17 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 189 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 43 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 77 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 39 | $0.00 |
| 36416 | 0% | 109 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.